Fundraising Fox
60 Degrees Pharmaceuticals
NASDAQ: SXTPWashington, US · Founded 2022 · Delaware corporation · 1 known investors
Find your way into 60 Degrees Pharmaceuticals
67 people in our graph share verified history with the 60 Degrees Pharmaceuticals team — schools, employers, funds. One of them is your warm intro.
Matthew Hobsonunlockedknows Geoffrey S. Dow · together at Walter Reed Army Institute of Research (overlapped)
×2knows the team · via Walter Reed Army Institute of Research
×3knows the team · via Murdoch University
×5knows the team · via University of Maryland
knows the team · via 60 Degrees Pharmaceuticals
60 Degrees Pharmaceuticals develops treatments and preventive medicines for vector-borne diseases such as babesiosis and malaria. Founded in 2010, the company focuses on tick-borne and parasitic infections affecting patients and travelers globally.
Founders & leadership
60 Degrees Pharmaceuticals was founded in 2022 by Geoffrey S. Dow.
GS
Geoffrey S. DowChief Executive Officer and PresidentGeoffrey S. Dow is Chief Executive Officer and President of 60 Degrees Pharmaceuticals, which develops treatments and preventive medicines for vector-borne diseases including babesiosis and malaria.
Investors · 1
Also in the syndicate · 1
Knight Therapeutics Inc.
Funding
SEC filings, press & company announcements$3.9M disclosed across 3 of 5 rounds · 2022–2026
- Undisclosed amountprivate placementJul 2026Source ↗
▶$1.1MraisedFeb 2025 · 4 investors · PharmaceuticalsRule 506(b)
▶$1.1MraisedFeb 2025 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Geoffrey S. DowExecutive Officer, Director
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- Sales commissions
- $91.4K
- Placement agents
- H.C.WAINWRIGHT & CO., LLC
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$1MraisedFeb 2025 · 4 investors · PharmaceuticalsRule 506(b)
▶$1MraisedFeb 2025 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Geoffrey S. DowExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- Sales commissions
- $88.7K
- Placement agents
- H.C.WAINWRIGHT & CO., LLC
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$1.8MraisedMay 2023 · 10 investors · PharmaceuticalsRule 506(b)
▶$1.8MraisedMay 2023 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Geoffrey S. DowExecutive Officer, Director
- Amount sold
- $1.8M
- Sales commissions
- $200.5K
- Placement agents
- WALLACHBETH CAPITAL LLC, CRAFT CAPITAL MANAGEMENT LLC
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$4.3Mvaluation at IPOJan 2024 · $0.39/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Competitors · 2
by search overlap
Doctronic10 shared keywordsDoctronic builds an AI system trained on peer-reviewed medical evidence to provide 24/7 medical triage and consultation, achieving 99.2% alignment with board-certified clinicians. The platform serves patients seeking instant healthcare guidance with no insurance requirement, anonymity, and HIPAA compliance.
Medscape10 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Companies competing with 60 Degrees Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does 60 Degrees Pharmaceuticals do?
- 60 Degrees Pharmaceuticals develops treatments and preventive medicines for vector-borne diseases such as babesiosis and malaria. Founded in 2010, the company focuses on tick-borne and parasitic infections affecting patients and travelers globally.
- Who founded 60 Degrees Pharmaceuticals?
- 60 Degrees Pharmaceuticals was founded by Geoffrey S. Dow in 2022.
- How much funding has 60 Degrees Pharmaceuticals raised?
- 60 Degrees Pharmaceuticals has disclosed $3.9M raised across 3 of its 5 known rounds.
- Where is 60 Degrees Pharmaceuticals headquartered?
- 60 Degrees Pharmaceuticals is headquartered in Washington, US.